COMMUNIQUÉS West-GlobeNewswire

Results from Clinical Trial Show Progenics’ PyL (18F-DCFPyL) PSMA PET/CT Imaging Agent Changes Management Plans for More Than 87% of Patients
24/04/2019
Data from a Prospectively Designed Independent Trial of 130 Patients showed that PyL upstaged and downstaged disease in 65.5% of patients NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. ( [...]
Shockwave Medical to Report First Quarter 2019 Financial Results on May 8, 2019
24/04/2019
SANTA CLARA, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Establishment Labs to Announce First Quarter 2019 Financial Results
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Wildflower Featured in CannabisNewsWire Publication Spotlighting Spectacular Growth in Cannabis Market
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Portola Pharmaceuticals Announces Retirement of Dr. John Curnutte, Executive Vice President and Head of Research and Development
24/04/2019
SOUTH SAN FRANCISCO, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Dr. John Curnutte, M.D., Ph.D., Executive Vice President and Head of Research and [...]
QBioMed Research Partner Mannin Research to Attend ARVO 2019 Annual Meeting
24/04/2019
NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc . (OTCQB: QBIO ), a biotechnology acceleration company, announced today its technology partner Mannin Research will be attending ARVO 2019 the Annual Meeting of [...]
Foamix Pharmaceuticals First Quarter 2019 Financial Results Conference Call & Webcast Scheduled for May 8
24/04/2019
REHOVOT, Israel and BRIDGEWATER, N.J., April 24, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Ceapro Inc. to Present at the ThinkEquity Conference in New York City
24/04/2019
– Presentation with live audio webcast Thursday, May 2, 2019 at 9:00 AM EDT – EDMONTON, Alberta, April 24, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology [...]
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
24/04/2019
LAVAL, Quebec, April 24, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Dynacare Announces Vito Ciciretto as new CEO
24/04/2019
BRAMPTON, Ontario, April 24, 2019 (GLOBE NEWSWIRE) -- Dynacare, a Canadian health and wellness solutions company, has announced that, effective immediately, Vito Ciciretto will assume the role of Chief Executive Officer [...]
Dynacare annonce la nomination de son nouveau PDG, Vito Ciciretto
24/04/2019
BRAMPTON, Ontario, 24 avr. 2019 (GLOBE NEWSWIRE) -- Dynacare, une entreprise canadienne qui offre des solutions en matière de santé et de mieux-être, annonce qu’à compter d’aujourd’hui, Vito Ciciretto assumera les [...]
Psychemedics Test for Fentanyl Detection Cleared by FDA
24/04/2019
Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse [...]
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Générale’s Strategic Review
24/04/2019
HENDERSON, Nev., April 24, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
Surgery Partners, Inc. Announces First Quarter 2019 Earnings Release Date and Conference Call Details
24/04/2019
NASHVILLE, Tenn., April 24, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]
Maverick Technology Solutions Announces the Addition of Douglas Leighton to Their Advisory Board
24/04/2019
Industry Icon and Influencer Brings Tremendous Track Record of Accelerating Ground Breaking Companies RENO, Nev., April 24, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), manufacturer of the highly [...]
Canada House Wellness Group Announces Appointment of Michael Orrbrooke as Chief Revenue Officer and Issuance of Shares and Stock Options
24/04/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 24, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or [...]
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
24/04/2019
FRAMINGHAM, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of products for dermal science and biosurgical applications, today announced that the [...]
Strongbridge Biopharma plc to Host First Quarter 2019 Financial Results Conference Call on May 1, 2019
24/04/2019
DUBLIN, Ireland and TREVOSE, Pa., April 24, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Radient Technologies Inc. Issues Shares for Services
24/04/2019
EDMONTON, Alberta, April 24, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) has issued an aggregate of 249,743 common shares to third party consultants [...]

Pages